Filing Details

Accession Number:
0001567619-21-006887
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-24 18:11:10
Reporting Period:
2021-03-22
Accepted Time:
2021-03-24 18:11:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584999 A. Vincent Miller C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-22 3,200 $4.73 23,333 No 4 M Direct
Common Stock Disposition 2021-03-22 3,200 $49.00 20,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-03-22 1,600 $0.00 1,600 $4.73
Common Stock Stock Option (Right to Buy) Disposition 2021-03-22 1,600 $0.00 1,600 $4.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,397 2029-08-08 No 4 M Direct
12,785 2029-08-08 No 4 M Direct
Footnotes
  1. Includes 1,808 Restricted Stock Units.
  2. The option is early exercisable. One twenty-fourth (1/24th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
  3. The option is early exercisable. One twelfth (1/12th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 27, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.